As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort

Christopher Alexander Hinze; Rainer Ehmann; Margret Jandl; Katrin Milger; Olaf Schmidt; Christian Schulz; Dirk Skowasch; Tobias Welte; Roland Buhl; Eckard Hamelmann; Marco Idzko; Christian Taube; Stephanie Korn; Hendrik Suhling

doi:10.1183/23120541.00741-2023

As-needed low-dose inhaled corticosteroid/formoterol therapy in patients with severe asthma included in the German Asthma Net cohort

ERJ Open Res. 2024 Apr 8;10(2):00741-2023. doi: 10.1183/23120541.00741-2023. eCollection 2024 Mar.

Authors

Christopher Alexander Hinze¹, Rainer Ehmann², Margret Jandl³, Katrin Milger⁴, Olaf Schmidt⁵, Christian Schulz⁶, Dirk Skowasch⁷, Tobias Welte¹, Roland Buhl⁸, Eckard Hamelmann⁹, Marco Idzko¹⁰, Christian Taube¹¹, Stephanie Korn^{12

13}, Hendrik Suhling^{1

13}

Affiliations

¹ Department of Respiratory Medicine and Infectious Disease, Hannover Medical School, Hannover, Germany.
² Ambulante Pneumologie Stuttgart, Stuttgart, Germany.
³ Hamburger Institut für Therapieforschung GmbH, Hamburg, Germany.
⁴ Department of Medicine V, Ludwig-Maximilians-University of Munich, University Hospital, Munich, Germany.
⁵ Pneumologische Gemeinschaftspraxis und Studienzentrum KPPK, Koblenz, Germany.
⁶ Bereich Pneumologie Klinik und Poliklinik für Innere Medizin II, University Hospital Regensburg, Regensburg, Germany.
⁷ Department of Internal Medicine II, Cardiology, Pneumology and Angiology, University Hospital Bonn, Bonn, Germany.
⁸ Pulmonary Department, Mainz University Hospital, Mainz, Germany.
⁹ Univ.-Klinik für Kinder- und Jugendmedizin, Evangelisches Klinikum Bethel, Bielefeld, Germany.
¹⁰ Department of Respiratory Medicine, Medical University of Vienna, Vienna, Austria.
¹¹ Department of Pulmonary Medicine, University Medical Center Essen-Ruhrlandklinik, Essen, Germany.
¹² IKF Pneumologie Mainz and Thoraxklinik Heidelberg, Mainz and Heidelberg, Germany.
¹³ These authors contributed equally.

Abstract

After the GINA update in 2019, the proportion of SMART therapy increased with evidence for better disease control in SMART patients compared to SABA alone https://bit.ly/3SSPX1C.